United Kingdom · Series A startup

Who invested in IMU Biosciences

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIBiotechHealthcare

Raised 5 months ago

Funding summaryUpdated 5 Nov 2026

$68Mraised across 2 rounds since 2024, from 3 sources

$15MSeries A$53MSeries A
Latest round
Series A, $53MJun 2026
Led by
IQ Capital and Molten Ventures
Step-upi
3.6×
Investors
4 (2 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202420252026
$15MSeries A$53MSeries A
First round
Series A, $15M
Jan 2024
Biggest round
$53M
Series A · Jun 2026
Between rounds
2.4 years
from the last two

The rounds

  1. Jun 2026
    Series A$53M3 new1 returning

    Reported by Ventureburn and 1 other

  2. Jan 2024
    Series A$15M1 new

    Source recorded

Founders and team

From IMU Biosciences's own website: 2 founders, 8 on the team.

Adam Laing PhDCo-founder & Chief Scientific Officer
Thomas Hayday PhDCo-founder & Chief Research Officer
  • John Baker PhDChief Executive Officer
  • Victoria Statham PhDChief Legal Officer
  • Dan ReederHead of PMO Diagnostic Products
  • Andrea PollardSenior Scientist
  • Caitlin SmithLab Manager
  • Clara DuboisProject Manager
  • Computational ImmunologyBoard of Directors
  • Hawo AliDirector of Project Management

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Molten VenturesVC firm2rounds, led 1
IQ CapitalVC firm1round, led 1
British Business BankCorporate VC1round
MeltwindVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list IMU Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

ExpaVC firmPer its own site
LifeX VenturesVC firmPer its own site

Quick answers about IMU Biosciences

Who invested in IMU Biosciences?

IMU Biosciences's investors include Molten Ventures, IQ Capital, British Business Bank and Meltwind. IQ Capital led its latest round.

How much has IMU Biosciences raised?

IMU Biosciences has raised $68M across 2 rounds since 2024.

When did IMU Biosciences last raise?

IMU Biosciences's most recent round was a Series A of $53M in Jun 2026, led by IQ Capital.

What was IMU Biosciences's biggest round?

Its most recent round, $53M in Jun 2026, is also its largest on record.

Who backed IMU Biosciences first?

IMU Biosciences's first round on record, in Jan 2024, was backed by Molten Ventures.

What stage is IMU Biosciences at?

IMU Biosciences's latest named round is a Series A, in Jun 2026.

Where is IMU Biosciences based?

IMU Biosciences is based in the United Kingdom.

Who led IMU Biosciences's rounds?

IQ Capital led the Series A in 2026.

Companies like IMU Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.